🇰🇿 Country Profile

Kazakhstan

Medicine from India reaching Kazakhstan

🇰🇿 $89.0M
All data from DGCIS India export records (fiscal year, April–March).
$89.0M
Scale
Kazakhstan's patients receive $89.0M in Indian pharmaceutical products annually, almost entirely finished medicines ready for dispensing.
83%
Medicine
Overwhelmingly finished medicines, drug formulations account for 83% of shipments.
1.7×
Trajectory
India's pharmaceutical supply to Kazakhstan has grown 1.7× over the past decade, strong, sustained expansion.
Context
Part of India's pharmaceutical supply network across Europe.
Impact
Indian pharmaceutical companies have both exported to and invested directly in Kazakhstan, building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix, FY 2025–26 DGCIS
Medicines $74.3M (83.5%) Traditional & Herbal $8.1M (9.1%) Vaccines $3.5M (3.9%) Medicine Ingredients $1.6M (1.8%) Surgical & Hospital Supplies $1.6M (1.8%)
Top Products, FY 2025–26 DGCIS
Indian Pharma Investment in Kazakhstan Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Kazakhstan: $9.2M across 7 filings (2012-2025).